Text size
related tags

The Israeli biomedical company Prolor Biotech has been sold to OPKO Health for $7 a share, giving the company a value of $480 million, both companies announced Wednesday. Although a final agreement was signed, the transaction is still subject to certain conditions, including the approval from the shareholders of both companies.